Co-morbidities in HF

Published: 31 July 2020

  • Views:

    Views Icon 177
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This session was part of the 1st e-SPACE Heart Failure Meeting held virtually on July 11-14th 2020 and focuses on commonly encountered co-morbidities encountered when managing and treating Heart Failure patients; such as Iron Deficiency, Hyperkalemia, CKD and Frailty.

Agenda

Session - Speaker

  • Chronic Kidney Disease - Clyde Yancy (Northwestern University Feinberg School of Medicine, Chicago, US)
  • Hyperkalemia - Javed Butler (University of Tennessee, Knoxville, US)
  • Iron Deficiency with and without Anaemia - Piotr Ponikowski (Wroclaw Medical University, Wroclaw, Poland)
  • Exercise and Managing Frailty - Shigeru Makita (Saitama Medical University, Hidaka, JP)

More from this programme

Part 1

Chronic Kidney Disease

Part 2

Hyperkalemia

Part 3

Iron Deficiency with and without Anaemia

Part 4

Exercise and managing frailty

Faculty Biographies

Piotr Ponikowski

Piotr Ponikowski

Head of the Department of Heart Diseases

Piotr Ponikowski is Head of the Department of Heart Diseases, Wroclaw Medical University and Head of the Cardiology Department at the Center for Heart Diseases at 4th Military Hospital, Wroclaw, Poland. His research interests mainly include heart failure (HF), coronary artery disease and cardiac arrhythmias. He has been involved in numerous research projects, such as the benefits of physical rehabilitation in patients with chronic HF, assessment of metabolic derangements in HF (with special interest in iron deficiency), evaluation of reflex control in the cardiorespiratory system in order to optimise assessment and management of patients with HF. He has been involved in numerous clinical trials as main investigator, member of international steering committees, endpoint committees and advisory boards.

View full profile